Abbott Dividend Yield vs Accounts Payable Analysis

ABT Stock

USD 105.27 0.63 0.59%

Abbott Laboratories financial indicator trend analysis is way more than just evaluating Abbott Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abbott Laboratories is a good investment. Please check the relationship between Abbott Laboratories Dividend Yield and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Dividend Yield vs Accounts Payable

Dividend Yield vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abbott Laboratories Dividend Yield account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Abbott Laboratories' Dividend Yield and Accounts Payable is -0.46. Overlapping area represents the amount of variation of Dividend Yield that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Abbott Laboratories, assuming nothing else is changed. The correlation between historical values of Abbott Laboratories' Dividend Yield and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Dividend Yield of Abbott Laboratories are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Dividend Yield i.e., Abbott Laboratories' Dividend Yield and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.46

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Dividend Yield

Dividend Yield is Abbott Laboratories dividend as a percentage of Abbott Laboratories stock price. Abbott Laboratories dividend yield is a measure of Abbott Laboratories stock productivity, which can be interpreted as interest rate earned on an Abbott Laboratories investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Accounts Payable

An accounting item on the balance sheet that represents Abbott Laboratories obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Abbott Laboratories are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Abbott Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abbott Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.At this time, Abbott Laboratories' Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 19.89 in 2024, whereas Tax Provision is likely to drop slightly above 949.8 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	24.5B	24.5B	22.1B	12.5B
Total Revenue	43.1B	43.7B	40.1B	22.2B

Gross Profit Total Revenue

Abbott Laboratories fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Accounts Payable	Current Deferred Revenue	Common Stock Total Equity	Short Term Investments
Total Assets		0.87	0.69	0.77	0.75	0.92	0.77	0.61	0.49	0.82	0.23	0.45	0.84	0.3	0.89	0.61	0.15	-0.05	0.97	0.41	0.74	-0.18	0.63	-0.3	0.67	-0.06
Short Long Term Debt Total	0.87		0.45	0.44	0.53	0.65	0.79	0.4	0.68	0.71	0.18	0.6	0.6	0.22	0.99	0.37	-0.03	0.0	0.95	0.18	0.68	-0.36	0.42	-0.29	0.51	-0.16
Other Current Liab	0.69	0.45		0.9	0.78	0.8	0.41	0.69	0.24	0.69	0.08	0.29	0.9	-0.13	0.47	0.76	0.47	-0.42	0.67	0.65	0.67	0.19	0.67	-0.07	0.55	0.17
Total Current Liabilities	0.77	0.44	0.9		0.68	0.86	0.37	0.62	0.27	0.58	0.13	0.32	0.93	0.02	0.46	0.62	0.57	-0.37	0.69	0.51	0.73	0.34	0.53	-0.16	0.44	0.18
Total Stockholder Equity	0.75	0.53	0.78	0.68		0.84	0.55	0.93	0.2	0.92	0.19	0.17	0.68	-0.06	0.54	0.94	0.1	0.1	0.65	0.82	0.49	-0.06	0.89	-0.36	0.94	-0.06
Property Plant And Equipment Net	0.92	0.65	0.8	0.86	0.84		0.61	0.75	0.33	0.81	0.21	0.31	0.86	0.21	0.67	0.78	0.22	-0.08	0.82	0.62	0.69	-0.06	0.74	-0.24	0.74	-0.03
Net Debt	0.77	0.79	0.41	0.37	0.55	0.61		0.29	0.09	0.82	0.35	0.03	0.52	0.42	0.85	0.4	-0.17	-0.01	0.81	0.13	0.26	-0.43	0.49	-0.14	0.61	-0.2
Retained Earnings	0.61	0.4	0.69	0.62	0.93	0.75	0.29		0.31	0.76	0.1	0.27	0.56	-0.29	0.37	0.91	0.13	0.16	0.5	0.85	0.5	0.1	0.8	-0.42	0.86	-0.09
Cash	0.49	0.68	0.24	0.27	0.2	0.33	0.09	0.31		0.17	-0.12	0.95	0.35	-0.14	0.59	0.13	0.16	0.0	0.57	0.13	0.79	-0.08	0.1	-0.31	0.11	-0.02
Non Current Assets Total	0.82	0.71	0.69	0.58	0.92	0.81	0.82	0.76	0.17		0.29	0.08	0.66	0.15	0.74	0.83	-0.09	0.05	0.79	0.64	0.39	-0.28	0.86	-0.27	0.93	-0.25
Non Currrent Assets Other	0.23	0.18	0.08	0.13	0.19	0.21	0.35	0.1	-0.12	0.29		-0.17	0.13	0.25	0.21	0.17	-0.15	0.07	0.21	0.03	-0.05	-0.08	0.24	0.1	0.26	-0.16
Cash And Short Term Investments	0.45	0.6	0.29	0.32	0.17	0.31	0.03	0.27	0.95	0.08	-0.17		0.38	-0.23	0.52	0.07	0.37	-0.01	0.52	0.06	0.87	0.06	-0.01	-0.32	0.0	0.3
Net Receivables	0.84	0.6	0.9	0.93	0.68	0.86	0.52	0.56	0.35	0.66	0.13	0.38		0.19	0.63	0.64	0.4	-0.32	0.81	0.51	0.76	0.08	0.61	-0.02	0.48	0.14
Common Stock Shares Outstanding	0.3	0.22	-0.13	0.02	-0.06	0.21	0.42	-0.29	-0.14	0.15	0.25	-0.23	0.19		0.3	-0.04	-0.48	0.15	0.26	-0.07	-0.12	-0.64	0.21	0.42	0.08	-0.31
Non Current Liabilities Total	0.89	0.99	0.47	0.46	0.54	0.67	0.85	0.37	0.59	0.74	0.21	0.52	0.63	0.3		0.38	-0.05	-0.01	0.96	0.17	0.64	-0.41	0.46	-0.23	0.53	-0.16
Inventory	0.61	0.37	0.76	0.62	0.94	0.78	0.4	0.91	0.13	0.83	0.17	0.07	0.64	-0.04	0.38		0.0	0.11	0.51	0.92	0.39	-0.11	0.95	-0.12	0.9	-0.15
Other Current Assets	0.15	-0.03	0.47	0.57	0.1	0.22	-0.17	0.13	0.16	-0.09	-0.15	0.37	0.4	-0.48	-0.05	0.0		-0.42	0.14	-0.03	0.56	0.8	-0.21	-0.31	-0.22	0.67
Other Stockholder Equity	-0.05	0.0	-0.42	-0.37	0.1	-0.08	-0.01	0.16	0.0	0.05	0.07	-0.01	-0.32	0.15	-0.01	0.11	-0.42		-0.13	0.1	-0.18	-0.33	0.15	-0.11	0.28	-0.05
Total Liab	0.97	0.95	0.67	0.69	0.65	0.82	0.81	0.5	0.57	0.79	0.21	0.52	0.81	0.26	0.96	0.51	0.14	-0.13		0.3	0.75	-0.23	0.54	-0.24	0.58	-0.07
Property Plant And Equipment Gross	0.41	0.18	0.65	0.51	0.82	0.62	0.13	0.85	0.13	0.64	0.03	0.06	0.51	-0.07	0.17	0.92	-0.03	0.1	0.3		0.3	-0.07	0.87	-0.04	0.78	-0.18
Total Current Assets	0.74	0.68	0.67	0.73	0.49	0.69	0.26	0.5	0.79	0.39	-0.05	0.87	0.76	-0.12	0.64	0.39	0.56	-0.18	0.75	0.3		0.17	0.28	-0.31	0.25	0.34
Short Term Debt	-0.18	-0.36	0.19	0.34	-0.06	-0.06	-0.43	0.1	-0.08	-0.28	-0.08	0.06	0.08	-0.64	-0.41	-0.11	0.8	-0.33	-0.23	-0.07	0.17		-0.34	-0.3	-0.3	0.44
Accounts Payable	0.63	0.42	0.67	0.53	0.89	0.74	0.49	0.8	0.1	0.86	0.24	-0.01	0.61	0.21	0.46	0.95	-0.21	0.15	0.54	0.87	0.28	-0.34		-0.02	0.92	-0.32
Current Deferred Revenue	-0.3	-0.29	-0.07	-0.16	-0.36	-0.24	-0.14	-0.42	-0.31	-0.27	0.1	-0.32	-0.02	0.42	-0.23	-0.12	-0.31	-0.11	-0.24	-0.04	-0.31	-0.3	-0.02		-0.32	-0.07
Common Stock Total Equity	0.67	0.51	0.55	0.44	0.94	0.74	0.61	0.86	0.11	0.93	0.26	0.0	0.48	0.08	0.53	0.9	-0.22	0.28	0.58	0.78	0.25	-0.3	0.92	-0.32		-0.33
Short Term Investments	-0.06	-0.16	0.17	0.18	-0.06	-0.03	-0.2	-0.09	-0.02	-0.25	-0.16	0.3	0.14	-0.31	-0.16	-0.15	0.67	-0.05	-0.07	-0.18	0.34	0.44	-0.32	-0.07	-0.33

Click cells to compare fundamentals

Abbott Laboratories Account Relationship Matchups

Abbott Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	67.9B	72.5B	75.2B	74.4B	73.2B	36.9B
Short Long Term Debt Total	18.9B	19.6B	19.0B	17.7B	15.9B	9.8B
Other Current Liab	6.1B	7.7B	7.9B	8.6B	7.7B	8.1B
Total Current Liabilities	10.9B	11.9B	13.1B	15.5B	13.8B	8.3B
Total Stockholder Equity	31.1B	32.8B	35.8B	36.7B	38.6B	40.5B
Property Plant And Equipment Net	8.0B	9.0B	9.0B	9.2B	11.3B	6.2B
Net Debt	15.0B	12.8B	9.2B	7.8B	9.0B	6.1B
Retained Earnings	25.8B	27.6B	31.5B	35.3B	37.6B	39.4B
Cash	3.9B	6.8B	9.8B	9.9B	6.9B	3.7B
Non Current Assets Total	52.2B	52.1B	51.0B	49.2B	50.5B	53.1B
Non Currrent Assets Other	52.2B	3.7B	5.2B	6.0B	6.0B	3.1B
Cash And Short Term Investments	4.1B	7.1B	10.2B	10.2B	7.3B	4.3B
Net Receivables	5.4B	6.4B	6.5B	8.9B	6.6B	3.9B
Common Stock Shares Outstanding	1.8B	1.8B	1.8B	1.8B	1.8B	1.3B
Liabilities And Stockholders Equity	67.9B	72.5B	75.2B	74.4B	73.2B	36.9B
Non Current Liabilities Total	25.7B	27.6B	26.1B	22.0B	20.5B	11.7B
Inventory	4.3B	5.0B	5.2B	6.2B	6.6B	6.9B
Other Current Assets	1.8B	1.9B	2.3B	2.7B	2.3B	2.2B
Other Stockholder Equity	(10.1B)	(10.0B)	(11.8B)	(15.2B)	(16.0B)	(16.8B)
Total Liab	36.6B	39.5B	39.2B	37.5B	34.4B	20.0B
Property Plant And Equipment Gross	8.0B	9.0B	19.4B	20.2B	21.9B	23.0B
Total Current Assets	15.7B	20.4B	24.2B	25.2B	22.7B	13.3B
Accumulated Other Comprehensive Income	(8.5B)	(8.9B)	(8.4B)	(8.1B)	(7.8B)	(7.4B)
Short Term Debt	207M	1.5B	220M	754M	2.3B	2.0B
Accounts Payable	3.3B	3.9B	4.4B	4.6B	4.3B	4.5B
Common Stock Total Equity	23.9B	24.1B	24.5B	24.7B	28.4B	29.8B
Short Term Investments	280M	310M	450M	288M	383M	757.2M
Common Stock	23.9B	24.1B	24.5B	24.7B	24.9B	23.6B
Intangible Assets	17.0B	14.8B	12.7B	10.5B	8.8B	9.1B
Other Liab	8.3B	8.2B	7.8B	6.6B	7.6B	5.7B
Other Assets	2.4B	2.8B	4.1B	4.9B	5.7B	5.9B
Long Term Debt	16.7B	18.5B	17.3B	14.5B	13.6B	12.0B
Treasury Stock	(10.0B)	(10.1B)	(10.0B)	(11.8B)	(10.6B)	(10.1B)
Property Plant Equipment	8.0B	9.0B	9.0B	9.2B	10.5B	7.7B
Good Will	23.2B	23.7B	23.2B	22.8B	23.7B	15.5B
Net Tangible Assets	(70M)	3.4B	(2.2B)	11.0B	9.9B	10.4B
Noncontrolling Interest In Consolidated Entity	198M	213M	219M	222M	251.9M	163.8M
Retained Earnings Total Equity	25.8B	27.6B	31.5B	35.3B	40.5B	27.2B
Long Term Debt Total	16.7B	18.5B	17.3B	14.5B	16.7B	15.8B

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving against Abbott Stock

0.44	GCTK	GlucoTrack	Pair Corr
0.43	WST	West Pharmaceutical Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.

The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:

How To Invest In Abbott

Details

Is Abbott Stock a good investment?

Details

What is Abbott Laboratories' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Commodity Directory Find actively traded commodities issued by global exchanges
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Transaction History View history of all your transactions and understand their impact on performance
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing

Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.07)

Dividend Share

2.12

Earnings Share

3.21

Revenue Per Share

23.183

Quarterly Revenue Growth

0.022

The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abbott Dividend Yield vs Accounts Payable Analysis

Dividend Yield vs Accounts Payable

Dividend Yield vs Accounts Payable Correlation Analysis

Correlation Coefficient

Dividend Yield

Accounts Payable

Abbott Laboratories fundamental ratios Correlations

Abbott Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Abbott Laboratories fundamental ratios Accounts

Pair Trading with Abbott Laboratories

Moving against Abbott Stock

Complementary Tools for Abbott Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.97	Total Assets
Total Liab	+ 0.96	Non Current Liabilities Total
Total Liab	+ 0.95	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.95	Cash
Accounts Payable	+ 0.95	Inventory

Short Term Debt	- 0.64	Common Stock Shares Outstanding
Other Current Assets	- 0.48	Common Stock Shares Outstanding
Short Term Debt	- 0.43	Net Debt
Other Stockholder Equity	- 0.42	Other Current Assets
Current Deferred Revenue	- 0.42	Retained Earnings
Other Stockholder Equity	- 0.42	Other Current Liab